24/7 Market News Snapshot 13 January, 2025 – Alignment Healthcare, Inc. Common Stock (NASDAQ:ALHC)
DENVER, Colo., 13 January, 2025 (247marketnews.com) – (NASDAQ:ALHC) are discussed in this article.
Alignment Healthcare, Inc. opened trading today at $11.95, quickly climbing to $13.23, marking an impressive increase of 11.39% from the previous closing price of $11.88. This surge is underscored by a significant trading volume of 2.41 million shares, indicating heightened investor interest and robust bullish sentiment. Analysts suggest that if ALHC can maintain this trading momentum and break through a resistance level at $13.50, further gains could be on the horizon. Traders are advised to observe volume trends closely, with potential support anticipated around $12.00, to better gauge the stock’s future trajectory.
In tandem with its current market performance, Alignment Healthcare has reported striking growth in its Medicare Advantage membership base, achieving a year-over-year increase of 35%, totaling approximately 209,900 members as of January 1, 2025. The company projects additional growth, anticipating an increase to between 225,000 and 231,000 members by year-end 2025, reflecting a projected growth rate of 22% to 25%. This ambition is complemented by a target consensus adjusted EBITDA of about $40 million for 2025, highlighting Alignment’s confidence in its strategic vision.
CEO John Kao reaffirmed that the company’s ongoing success is a direct result of its focus on senior-centered care. He stated, “Our continued growth underscores the effectiveness of our model and our dedication to delivering high-quality, low-cost care.” Additionally, the promotion of Dawn Maroney to President signifies a commitment to enhance member experiences and provider engagement, further driving operational excellence.
Alignment Healthcare’s performance is also evident in its noteworthy member ratings, with over 98% of its health plan members enrolled in plans rated four stars or higher for 2025. With a distinguished 5-star rating from the Centers for Medicare & Medicaid Services for key contracts, the company is poised to continually enhance care quality and health outcomes in the evolving Medicare Advantage landscape.